Skip to Main Content

 

White Paper

Disruption in Healthcare Is Here: Are You Ready?

Engineering simulation, or the use of computer models to assess the behavior of a device or treatment in its working environment, is now used by 85% of the top 50 healthcare companies as part of their product and process development.

Simulating the performance of drugs, devices and therapies in a low-risk, cost-effective virtual environment can develop (disruptive) innovations much faster and at lower cost. Healthcare pioneers have repeatedly reported returns on investment of greater than 500%.

Ansys is fully embracing the in silico approach by creating the necessary software and enabling access to computational power to make simulation pervasive from startups to large global companies, from concept to in-patient performance.

 

SHARE THIS WHITE PAPER

查看 Ansys 的服務與產品

立即聯絡我們

* = 必填欄位

感謝您聯絡我們!

我們將在此解答您的問題,並期待與您交流互動。Ansys 的銷售團隊成員會立即與您聯絡。

Footer Image